ECONSALUT

Pricing of cancer medicines and its impacts We all know that new cancer drugs represent a challenge for the whole society. Expectations fr...

Beyond Nudges — When Improving Health Calls for Greater Assertiveness From NEJM And a book:

After Enron, Valeant Pharmaceuticals is one of the largest corruption scandals of Wall Street. If you want to know the details, you just hav...

THE MORAL ECONOMY WHY GOOD INCENTIVES ARE NO SUBSTITUTE FOR GOOD CITIZENS For those interested in pay for performance, the book by Samuel...

Private Equity Acquisition of Physician Practices From Annals of Internal Medicine: The current environment is accelerating the disappea...

Digital is reshaping US health insurance—winners are moving fast From McKinsey Digital has begun to reshape health insurance markets. Pa...

The Contribution Of New Product Entry Versus Existing Product Inflation In The Rising Costs Of Drugs In the US there is a huge concern ov...

MODERN MONOPOLIES: What It Takes to Dominate the 21st-Century Economy Platform business is the hottest topic in organizational economics. ...

Contest models highlight inherent inefficiencies of scientific funding competitions Research funding needs reform. In PLOS Biology, you...

When All Else Fails: THE ETHICS OF RESISTANCE TO STATE INJUSTICE The economist Albert O. Hirschman famously argued that citizens of dem...

WILL POPULATION AGEING SPELL THE END OF THE WELFARE STATE? Too many people argue over the end of the welfare state. There are reasons for ...

Health at a Glance: Europe 2018 Every two years OECD publishes this report for the European Union on the state of health . The new one has...

THE MYTH OF CAPITALISM Monopolies and the Death of Competition These are some selected key messages from the book: Capitalism without c...

Pharmaceutical Innovation and Access to Medicines While in the last years the number of new drugs in the market has been limited, this tre...